Oriza Holdings logo

Oriza Holdings

Asia, Jiangsu, China, Suzhou

Description

Oriza Holdings is a prominent state-owned investment platform based in Suzhou, China, established in 2007. It operates as a comprehensive financial holding group, encompassing a wide array of services including equity investment, debt financing, and professional fund management. Its mandate extends to fostering economic development and industrial upgrading, primarily within the Yangtze River Delta region and across China, by deploying capital into strategic emerging industries.

The firm boasts a significant scale and influence within the Chinese investment landscape. Oriza Holdings manages assets exceeding 300 billion RMB, equivalent to approximately $41 billion USD, making it one of the largest state-backed investment entities in the country. This vast capital base enables it to establish and manage over 100 specialized funds, covering various stages from early-stage venture capital to mature private equity and industry-specific funds.

Oriza Holdings' investment strategy is comprehensive, targeting companies across their entire lifecycle, from nascent startups to established enterprises seeking growth capital or pre-IPO funding. The firm primarily focuses on high-growth sectors critical to China's economic transformation, including TMT (Technology, Media, and Telecommunications), biomedicine, new energy, and advanced manufacturing. With a robust portfolio of over 1,000 companies, Oriza Holdings plays a crucial role in nurturing innovation and supporting the industrial upgrade of its target regions.

Through its diversified fund structure and strategic focus, Oriza Holdings has cemented its position as a key driver of technological and industrial advancement in China. Its capacity to deploy significant capital across various stages and sectors underscores its strategic importance in shaping the nation's future economic landscape.

Investor Profile

Oriza Holdings has backed more than 42 startups, with 19 new investments in the last 12 months alone. The firm has led 5 rounds, about 12% of its total and boasts 16 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Manufacturing, Biotechnology, Health Care.
  • Led 4 rounds in the past year.
  • Typical check size: $2M – $100M.

Stage Focus

  • Series A (31%)
  • Series B (24%)
  • Series C (21%)
  • Seed (10%)
  • Series D (5%)
  • Series Unknown (5%)
  • Series E (2%)
  • Private Equity (2%)

Country Focus

  • China (86%)
  • United States (14%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Semiconductor
  • Electronics
  • Industrial
  • Pharmaceutical
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oriza Holdings frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 3
ff Venture Capital
North America, New York, United States, New York
Co-Investments: 3
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Correlation Ventures
North America, California, United States, San Diego
Co-Investments: 4
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 5
Oriza Ventures
North America, California, United States, Santa Clara
Co-Investments: 2
Walden International
North America, California, United States, San Francisco
Co-Investments: 2
CPE
Asia, Beijing, China, Beijing
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 3

What are some of recent deals done by Oriza Holdings?

Tiejin Technology

Suzhou, Jiangsu, China

Tiejin Technology is a humanoid robotics company that provides research and development related to micro and ultra-micro bearings.

IndustrialManufacturingRobotics
Private EquityJun 30, 2025
Amount Raised: $27,916,975
Xiaolu Biotech

Shanghai, Shanghai, China

Xiaolu Biotech is the developer of the Biopharmaceutical.

BiopharmaMedical
SeedJun 17, 2025
AECC Commercial Aircraft Engine

Minhang, Shanghai, China

AECC offers design, development, production, assembly, testing, and technical consulting of commercial aircraft power services.

AerospaceMachinery ManufacturingProduct DesignSales
Series AJun 6, 2025
scanner optics

Shenzhen, Guangdong, China

scanner optics is an enterprise integrating technology research and development, production and sales.

Series AMay 27, 2025
Magic Atom

Wuxi Shi, Jiangsu, China

Magic Atom is a robotics company that specializes in the development and application of robots and embodied intelligent technologies.

Intelligent SystemsManufacturingRobotics
SeedMay 15, 2025
Yunshen Technology

Putuo, Shanghai, China

Yunshen Technology is a manufacturing company that provides production and raw materials solutions for the semiconductor industry.

IndustrialMachinery ManufacturingMechanical EngineeringSemiconductor
Series AApr 14, 2025
Jingrui CNC Machine Tool

Shenyang, Liaoning, China

Jingrui CNC Machine Tool is a private enterprise focusing on the research and production of high-end CNC machine tools.

EnterpriseIntelligent SystemsManufacturing
Series AApr 7, 2025
ChipSine

Suzhou, Jiangsu, China

ChipSine is an Integrated Circuit (IC) design company that focuses on automotive-grade electronic control chips and solutions.

Application Specific Integrated Circuit (ASIC)ManufacturingSemiconductor
SeedMar 27, 2025
Amount Raised: $13,772,208
Yuanluo Technology

Haidian, Beijing, China

Yuanluo Technology is an innovative company focusing on the research and development and application of robot embodied technology.

Health CareLogisticsRoboticsService Industry
Series AFeb 27, 2025
Empower

Shanghai, Shanghai, China

Empower is an enterprise platform focused on intelligent laser manufacturing that makes lasers smart.

LaserManufacturing
Series BFeb 25, 2025